
GC39411
NL-1
Also known as 5-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidine-2,4-dione
NL-1 is a mitoNEET inhibitor with antileukemic effect· NL-1 inhibits REH and REH/Ara-C cells growth with IC50s of 47·35 ?M and 56·26 ?M, respectively· NL-1-mediated death in leukemic cells requires the activation of the autophagic pathway
ChemicalCAS188532-26-5MW335.46FormulaC18H25NO3S
- CAS number
- 188532-26-5
- Molecular weight
- 335.46
- Formula
- C18H25NO3S
- Solubility
- DMSO: 250 mg/mL (745·25 mM)
- InChIKey
- QDYYSPGKYXWGSL-UHFFFAOYSA-N
- Catalogue number
- GC39411
- Brand
- GLPBIO
Computed properties PubChem CID 9819104 · XLogP 5 · TPSA 91.7 Ų · H-bond donors 2
- XLogP
- 5
- TPSA
- 91.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 23
SMILES CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NC(=O)S2
Computed descriptors from PubChem (CID 9819104), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il